Frontiers in Pharmacology | Cardiovascular and Smooth Muscle Pharmacology

Original Research

Published on 15 Jan 2025

Drug-induced heart failure: a real-world pharmacovigilance study using the FDA adverse event reporting system database

in Cardiovascular and Smooth Muscle Pharmacology

Youqi Huang
Xiaowen Chen
Mingyu Chen
Yuze Lin
Bingqi Chen
Hongjin Gao
Min Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1523136

250 views

Original Research

Published on 15 Jan 2025

Effect of prophylactic doses of enoxaparin on antifactor Xa activity confirmed by rotational thromboelastometry in critically ill patients: a preliminary prospective cohort study

in Cardiovascular and Smooth Muscle Pharmacology

Piotr F. Czempik
Artur Beberok

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1498188

176 views

Review

Accepted on 13 Jan 2025

Role of Ferroptosis in Atrial Fibrillation: A Review

in Cardiovascular and Smooth Muscle Pharmacology

Shaowei Fan
Yuanhui Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1362060

Case Report

Accepted on 13 Jan 2025

From the Right Ventricle to the Descending Aorta: A Case Report of Complex Thrombotic Events in a Patient with Nephrotic Syndrome

in Cardiovascular and Smooth Muscle Pharmacology

Jiaojiao Chen
Longyin Zhu
Fen Zhou
Yuting Li
Tao Gu
菁夏

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1514801

Original Research

Published on 13 Jan 2025

Clopidogrel combined with rivaroxaban in peripheral artery disease after revascularization

in Cardiovascular and Smooth Muscle Pharmacology

Min Lu
Jiaqi Li
Huanyu Ni
Tong Qiao
Baoyan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1485380

175 views

Original Research

Accepted on 10 Jan 2025

Mechanism of Salvianolic Phenolic Acids and Hawthorn Triterpenic Acids Combination in Intervening Atherosclerosis: Network pharmacology, Molecular Docking and Experimental Validation

in Cardiovascular and Smooth Muscle Pharmacology

Qu Zhai
Shixi Shang
Zihan Zhang
Lihua Sun
Ying Huang
Shuyi Feng
Qian Wu
Haifeng Cui
Shi Xiaolu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1501846

Original Research

Published on 10 Jan 2025

Assembly of ceria-Nrf2 nanoparticles as macrophage-targeting ROS scavengers protects against myocardial infarction

in Cardiovascular and Smooth Muscle Pharmacology

Wenjing Liao
Jinduan Lin
Wenli Wang
Ming Zhang
Yanfang Chen
Xin Li
Huan Liu
Pan Xia Wang
Guojun Zhao
Jijun Fu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503757

200 views

Review

Published on 10 Jan 2025

Interplay between energy metabolism and NADPH oxidase-mediated pathophysiology in cardiovascular diseases

in Cardiovascular and Smooth Muscle Pharmacology

Haipeng Jie
Jingjing Zhang
Shuzhen Wu
Luyao Yu
Shengnan Li
Bo Dong
Feng Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503824

201 views

Review

Accepted on 09 Jan 2025

The Interplay of Ferroptosis and Oxidative Stress in the Pathogenesis of Aortic Dissection

in Cardiovascular and Smooth Muscle Pharmacology

Zhaoshan Zhang
Xi Kan
Xiaozhao Zhang
Senping Xu
Zhengdong Wan
Jiawei Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1519273

Review

Published on 07 Jan 2025

Gallic acid: a dietary metabolite’s therapeutic potential in the management of atherosclerotic cardiovascular disease

in Cardiovascular and Smooth Muscle Pharmacology

Xiao-Lan Zhao
Zhang-Jing Cao
Ke-Di Li
Fei Tang
Li-Yue Xu
Jing-Nan Zhang
Dong Liu
Cheng Peng
Hui Ao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1515172

155 views

Original Research

Published on 07 Jan 2025

Identification of ALEKSIN as a novel multi-IRF inhibitor of IRF- and STAT-mediated transcription in vascular inflammation and atherosclerosis

in Cardiovascular and Smooth Muscle Pharmacology

Aleksandra Antonczyk
Katarzyna Kluzek
Natalia Herbich
Mahdi Eskandarian Boroujeni
Bart Krist
Dorota Wronka
Anna Karlik
Lukasz Przybyl
Adam Plewinski
Joanna Wesoly

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1471182

332 views

Editorial

Published on 07 Jan 2025

Editorial: Chronobiology in cardiometabolic health and disease

in Cardiovascular and Smooth Muscle Pharmacology

Cristina Manuela Dragoi
Zhihong Yang
Baharan Fekry
Andrea Brenna

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1544963

234 views

Editorial

Published on 06 Jan 2025

Editorial: Insights in cardiovascular and smooth muscle pharmacology: 2023

in Cardiovascular and Smooth Muscle Pharmacology

Sönke Schildt
Daniel Reichart
Simon Lebek

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1544594

130 views

Editorial

Published on 06 Jan 2025

Editorial: Revealing the unconventional mechanisms of mitochondria-targeting drugs in heart-related diseases

in Cardiovascular and Smooth Muscle Pharmacology

Kaidi Ren
Yang Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1543291

150 views

Original Research

Published on 03 Jan 2025

Cardioprotective effects of the electrolyte solution sterofundin and the possible underlying mechanisms

in Cardiovascular and Smooth Muscle Pharmacology

Min Chen
Yingying Xiao
Jijian Zheng
Peibin Zhao
Lin Cheng
Chuan Jiang
Sixie Zheng
Zheng Wang
Sijuan Sun
Lincai Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1449831

190 views

Original Research

Published on 03 Jan 2025

Assessing the relationships of 1,400 blood metabolites with abdominal aortic aneurysm: a Mendelian randomization study

in Cardiovascular and Smooth Muscle Pharmacology

Qian Guo
Xinghua Xu
Xiaohui Li
Yang Mao
Shengqiang Li
Yuxin Yao
Xiang Li
Yaxing Li
Jiayue Feng
Yan Shu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1514293

240 views

Navigation group

Articles

Drug-induced heart failure: a real-world pharmacovigilance study using the FDA adverse event reporting system database

Effect of prophylactic doses of enoxaparin on antifactor Xa activity confirmed by rotational thromboelastometry in critically ill patients: a preliminary prospective cohort study

Role of Ferroptosis in Atrial Fibrillation: A Review

From the Right Ventricle to the Descending Aorta: A Case Report of Complex Thrombotic Events in a Patient with Nephrotic Syndrome

Clopidogrel combined with rivaroxaban in peripheral artery disease after revascularization

Mechanism of Salvianolic Phenolic Acids and Hawthorn Triterpenic Acids Combination in Intervening Atherosclerosis: Network pharmacology, Molecular Docking and Experimental Validation

Assembly of ceria-Nrf2 nanoparticles as macrophage-targeting ROS scavengers protects against myocardial infarction

Interplay between energy metabolism and NADPH oxidase-mediated pathophysiology in cardiovascular diseases

The Interplay of Ferroptosis and Oxidative Stress in the Pathogenesis of Aortic Dissection

Gallic acid: a dietary metabolite’s therapeutic potential in the management of atherosclerotic cardiovascular disease

Identification of ALEKSIN as a novel multi-IRF inhibitor of IRF- and STAT-mediated transcription in vascular inflammation and atherosclerosis

Editorial: Chronobiology in cardiometabolic health and disease

Editorial: Insights in cardiovascular and smooth muscle pharmacology: 2023

Editorial: Revealing the unconventional mechanisms of mitochondria-targeting drugs in heart-related diseases

Cardioprotective effects of the electrolyte solution sterofundin and the possible underlying mechanisms

Assessing the relationships of 1,400 blood metabolites with abdominal aortic aneurysm: a Mendelian randomization study